Chronic Kidney Disease (CKD) Treatment

Chronic Kidney Disease (CKD) Treatment: Medication, Lifestyle Changes, and More

Chronic Kidney Disease (CKD) Treatment: Medication, Lifestyle Changes, and More
iStock; Everyday Health
Chronic kidney disease (CKD) is a progressive condition in which the kidneys are damaged and can’t filter blood effectively. This can eventually lead to a buildup of waste and fluid in the body.

In the earlier stages of kidney disease, it’s possible to significantly slow down the progression of the disease with lifestyle changes. Treating related conditions, such as high blood pressure and diabetes, can also significantly improve your prognosis.

If the disease progresses to the point of kidney failure, there are only two treatment options: dialysis or a kidney transplant. There is currently no cure for CKD, and any loss of kidney function is irreversible.

If you have CKD, talk to your healthcare professional before starting a treatment or combining treatments, and discuss what’s best for you.

Medication

A number of prescription drugs can help manage CKD, including ones that treat diabetes and high blood pressure, two health conditions that are closely linked to this disease.

Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors

These drugs were developed to treat type 2 diabetes, but they are also effective at slowing down CKD progression.

SGLT2 inhibitors work by helping your kidneys remove more sugar and salt from your body through the urine. Medications in this class include:
  • canagliflozin (Invokana)
  • dapagliflozin (Farxiga)
  • empagliflozin (Jardiance)
Canagliflozin is an option specifically for people who have type 2 diabetes and CKD, but dapagliflozin and empagliflozin can both be used by people with CKD who don’t have diabetes.

Some possible side effects include more frequent urination, low blood pressure, and a decrease in estimated glomerular filtration rate (eGFR), which is a measurement of how well your kidneys are filtering waste and excess fluid from your blood.

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

Better known as the drug class that includes the weight loss phenomenon Ozempic (semaglutide), GLP-1s have also been approved by the U.S. Food and Drug Administration to treat people with type 2 diabetes and chronic kidney disease. These drugs protect the kidneys from damage by lowering blood sugar.

Other medications in this class include:
  • tirzepatide (Mounjaro, Zepbound)
  • dulglutide (Trulicity)
  • extendatide (Bydureon)
  • liraglutide (Victoza)

Renin-Angiotensin System Inhibitors (RASi)

This is a broader classification of drugs that includes ACE inhibitors and angiotensin II receptor blockers (ARBs). Both medications can protect the kidneys, and they’re also prescribed for high blood pressure and heart failure.

 Joseph A. Vassalotti, MD, the chief medical officer of the National Kidney Foundation and a clinical professor with the Icahn School of Medicine at Mount Sinai, says these drugs are often one of the first medications prescribed for CKD.
Medications in the ACE inhibitor class include:

  • lisinopril (Prinivil, Zestril)
  • perindopril (Aceon)
  • ramipril (Altace)
Medications in the ARB class include:

  • losartan (Cozaar)
  • olmesartan (Benicar)
  • valsartan (Diovan)
Common side effects of ARBs and ACE inhibitors include possible blood pressure drops, fatigue, and cough, which is more common with ACE than ARB medications.

Statins

Statins are medications that lower cholesterol to improve blood flow and prevent cardiovascular disease. Some evidence suggests that these meds may help with inflammation and slow down CKD progression.

Statins are considered a first-line therapy in people with CKD.

Some examples of statins include:

  • atorvastatin (Lipitor)
  • rosuvastatin (Crestor)
  • simvastatin (Zocor)
Possible side effects of statins include digestive problems, mental fuzziness, and muscle pain.

Diuretics

Diuretics help your body get rid of extra salt and fluid, which can help treat high blood pressure and also control the swelling that often accompanies kidney decline. Three different types of diuretics — thiazide, loop, and potassium-sparing — can be prescribed depending on how well your kidneys are working and which other health concerns you have.

Some of the diuretic drugs that can be used in CKD are:

  • bumetanide (Bumex)
  • chlorthalidone
  • furosemide (Lasix)
  • hydrochlorothiazide
  • metolazone
One loop diuretic, bumetanide, is approved in a nasal spray form (Enbumyst) that you can use at home to treat swelling associated with CKD. It’s meant to be a short-term solution for symptoms that get worse suddenly.


DRUG
WHAT IT DOES

Sodium-glucose cotransporter-2 (SGLT2) inhibitors

Causes kidneys to filter and expel more glucose from the bloodstream

Glucagon-like peptide (GLP-1) receptor agonists

Reduces blood sugar and prompts weight loss

Renin-angiotensin system inhibitors (RASi)

Relaxes blood vessels, lowering blood pressure

Statins

Reduces inflammation and lowers cholesterol

Diuretics

Removes extra salt and water through urine, lowering blood pressure and swelling

Dialysis

If your kidney disease progresses to kidney failure (end-stage kidney disease), your kidneys will no longer be able to work well enough to keep you alive. As a result, you will need a more serious intervention.

Dialysis, a treatment that filters waste and excess fluid from the blood, is one option. Options for dialysis include:

  • Hemodialysis This is the most common type. Hemodialysis can be done at home or in a dialysis center. It uses a machine that removes blood from a surgically created connection in your arm, filters it through an artificial kidney known as a dialyzer, and returns the cleaned blood to your body. Alternatively, a catheter may be placed in the upper chest. In-clinic visits are usually three days a week, while in-home dialysis may be daily.

  • Peritoneal Dialysis This type uses the lining of your abdomen to filter blood. There is no machine required, and it’s done every day at home. There is an initial surgery so that doctors can place the catheter for future fluid exchange.

  • Hemodiafiltration This type is similar to hemodialysis, but it adds an extra filtration process that removes more waste products from the blood. It’s not widely used in the United States, but it has a positive effect on mortality rates.

Dialysis is a significant burden, and it can greatly impact your quality of life.

Dr. Vassalotti says that in-center dialysis can be especially hard for patients, since it can be time-consuming. Patients need to come in “usually three times a week, for three to five hours,” he says. Patients can feel drained after dialysis treatment, often have to be on multiple medications, and can also struggle with the restricted diet that is necessary with this treatment.

Questions to Ask Your Doctor

  • How quickly is my kidney function declining?
  • What are my treatment options for chronic kidney disease?
  • What side effects should I expect from the medications you prescribe?
  • Will I need dialysis?
  • What dietary changes should I make to slow the progression of the disease?
  • What exercise and other lifestyle changes should I make to improve my prognosis?
  • How often should I be monitored?
  • When should I contact you or seek emergency care?
  • When do I become a candidate for a kidney transplant?

Kidney Transplantation

A kidney transplant may be the best option for people who have end-stage kidney disease. Compared with people who stay on dialysis, people who get a kidney transplant may live for about 10 years longer.

“A preemptive transplant is the first treatment for kidney failure,” says Vassalotti. He adds that a kidney from a live donor is the best way to obtain a healthy organ, and transplants are typically better for quality of life than dialysis.

Potential transplant recipients need to go through a transplant evaluation, which can involve multiple visits with specialists and evaluation tests, and many people spend two to five years on the waiting list. A kidney transplant surgery takes about five hours, and patients may spend a week at the hospital recovering.

After surgery, it could take several weeks for the kidney to start functioning. Dialysis may be necessary during this waiting time.

People who receive a kidney transplant will need to take immunosuppressive medications for the rest of their lives to prevent their bodies from rejecting the organ. These medications may have unpleasant side effects like nausea and can increase infection risk.

Dietary Changes

Your diet can have a big impact on kidney health, and healthy changes can significantly slow the progression of this chronic disease.

There is no one-size-fits-all kidney health diet. Your own dietary needs may differ depending on the stage of your CKD and other health factors, and they may change throughout the course of your treatment and progression.

“Most people with kidney disease should see a registered dietitian for medical nutrition therapy,” says Vassalotti. You should discuss these nutrients with your healthcare team.

  • Protein Your body breaks protein down into waste that’s removed from the blood. Some people with CKD may be advised to avoid eating too much protein, since this can make kidney function worse.

    Choosing plant-based sources of protein, like nuts, beans, and tofu, may also help slow CKD progression.

  • Potassium When the kidneys aren’t functioning properly, potassium levels can become high, leading to heart and muscle problems. High potassium is a risk in later stages of CKD, but even people who need to limit potassium should still eat plenty of fruits and vegetables for the other health benefits they offer.

  • Sodium Sodium is extremely common in processed and frozen foods, and keeping track of your salt intake can be beneficial for your kidney health. Limiting sodium might help with CKD progression and blood pressure.
  • Phosphorous Phosphorus, an important mineral, can build up in the bloodstream of people with CKD and harm your blood vessels and bones.

    Phosphorus is found in a wide variety of foods, including dairy products, salmon, meat, and poultry.

    The risk of phosphorus getting too high is typically greater later on in CKD.

Many people with CKD, especially during its earlier stages, will not have to limit nutrients like potassium and phosphorus. Choosing a healthy diet with plenty of fruits, veggies, whole grains, and minimally processed ingredients is a great start. Vassalotti recommends thinking about your overall dietary pattern and following healthy guidelines such as the U.S. Department of Agriculture (USDA) MyPlate concept. “Such an approach is more optimistic and useful than the focus on avoidance of certain foods,” he says.

Lifestyle Changes

Beyond following a relatively strict eating plan, other lifestyle changes may slow the progression of chronic kidney disease, improve quality of life, and minimize the chances of kidney failure.

  • Stay active. Physical activity may slow down worsening kidney function, although more research is needed.

    Physical activity can also help decrease heart disease risk and improve sleep.

  • Maintain a healthy weight. Both obesity and being underweight can pose risks for those who have CKD. Carrying extra weight can make the kidneys work harder, and being underweight is associated with an increased risk of developing end-stage kidney disease.

  • Avoid excessive alcohol. Binge drinking may contribute to CKD progression.

    The Centers for Disease Control and Prevention (CDC) recommends that people with CKD limit alcohol because of its impact on blood pressure.

  • Stop smoking. Smoking may speed the progression of CKD.

     Quitting smoking can also help decrease risk of premature death from cardiovascular disease.

Treat Related Conditions

Vassalotti says that diabetes, hypertension, heart disease, heart failure, and obesity are common conditions that often coexist with kidney disease. Treatment for those conditions can help control or slow the progression of your CKD.

  • Manage blood pressure. Good blood pressure control lowers the risks of cardiovascular events and all-cause mortality.

  • Lower cholesterol levels. Lowering your cholesterol can decrease the risk of atherosclerotic cardiovascular disease in those with CKD.

  • Stay on top of diabetes. Because these two health conditions are so closely interconnected, it’s essential to manage both. High blood sugar can speed up the decline of kidney function.

Your doctor may also prescribe a variety of other medications to treat the side effects or complications of chronic kidney disease. Iron supplements, for example, may be necessary to treat anemia, a possible complication of CKD. And potassium binders can help your body clear excess potassium.

The Takeaway

  • Chronic kidney disease is a progressive condition, but it can be managed through treatment. There currently is no cure.
  • Medications such as SGLT2 inhibitors, GLP-1 receptor agonists, renin–angiotensin system inhibitors, and statins can all help slow the progression of the disease.
  • Dialysis and kidney transplants are the only treatment options for those who have more advanced CKD.
  • Modify your diet, stay active, and quit smoking and drinking alcohol to give yourself a better quality of life with CKD.
EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Chronic Kidney Disease. Cleveland Clinic. May 7, 2023.
  2. Top 10 Takeaways for Nephrologists on the Management of People With CKD From the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Disease Improving Global Outcomes.
  3. Padda IS et al. Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors. StatPearls. September 15, 2025.
  4. Mende CW. Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment Landscape. Springer Nature Link. November 30, 2021.
  5. Jardiance Highlights of Prescribing Information. U.S. Food and Drug Administration. September 2023.
  6. SGLT2 inhibitors. National Kidney Foundation. December 6, 2024.
  7. Medicines to Manage Kidney Disease. American Kidney Fund.
  8. Bhandari S et al. Renin–Angiotensin System Inhibition in Advanced Chronic Kidney Disease. The New England Journal of Medicine. November 3, 2022.
  9. Angiotensin-Converting Enzyme (ACE) Inhibitors. Mayo Clinic. March 27, 2025.
  10. Agarwal R et al. Hypertension in Chronic Kidney Disease — Treatment Standard 2023. Nephrology Dialysis Transplantation. June 24, 2023.
  11. Types of Blood Pressure Medications. American Heart Association. August 14, 2025.
  12. Angiotensin-Converting enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs). American Kidney Fund. January 12, 2024.
  13. Wang J et al. Statins Have an Anti-Inflammation in CKD Patients: A Meta-Analysis of Randomized Trials. BioMed Research International. October 22, 2022.
  14. Top 10 Takeaways for People Living With CKD From the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Disease Improving Global Outcomes.
  15. Sizar O et al. Statin Medications. StatPearls. February 29, 2024.
  16. Statin Side Effects: Weigh the Benefits and Risks. Mayo Clinic. July 21, 2025.
  17. Diuretics. American Kidney Fund. March 11, 2024.
  18. ENBUMYST (bumetanide nasal spray) Highlights of Prescribing Information. Corstasis.
  19. Dialysis. Cleveland Clinic. March 28, 2025.
  20. Hemodialysis. Mayo Clinic. August 5, 2023.
  21. Peritoneal Dialysis. Mayo Clinic. May 2, 2023.
  22. Tattersall J et al. Technical Aspects of Hemodiafiltration. UpToDate. June 16, 2025.
  23. Guimaraes MCM et al. Hemodiafiltration Versus Hemodialysis in End-Stage Kidney Disease: A Systematic Review and Meta-Analysis. Kidney Medicine. April 17, 2024.
  24. Abramyan S et al. Kidney Transplantation. StatPearls. January 2, 2023.
  25. Kidney Transplant. Cleveland Clinic. December 18, 2024.
  26. Living-Donor Kidney Transplant. Mayo Clinic. June 28, 2024.
  27. Medications After Kidney Transplant. UC Davis Health.
  28. Healthy Eating for Adults With Chronic Kidney Disease. National Institute of Diabetes and Digestive and Kidney Diseases. January 2025.
  29. Alkhatib L et al. Lifestyle Modifications and Nutritional and Therapeutic Interventions in Delaying the Progression of Chronic Kidney Disease: A Review. Cureus. February 2, 2023.
  30. Rhee CM et al. Nutritional and Dietary Management of Chronic Kidney Disease Under Conservative and Preservative Kidney Care Without Dialysis. Journal of Renal Nutrition. June 30, 2023.
  31. High Potassium (Hyperkalemia). National Kidney Foundation. July 23, 2025.
  32. Ikizler TA. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. American Journal of Kidney Diseases. September 2020.
  33. Phosphorus. National Institutes of Health Office of Dietary Supplements. May 4, 2023.
  34. Schrauben SJ et al. Modifiable Lifestyle Behaviors and CKD Progression: A Narrative Review. Kidney 360. April 28, 2022.
  35. Living With Chronic Kidney Disease. Centers for Disease Control and Prevention. May 15, 2024.
  36. Kim CS et al. Underweight Status and Development of End-Stage Kidney Disease: A Nationwide Population-Based Study. Journal of Cachexia, Sarcopenia and Muscle. July 28, 2023.
  37. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Disease Improving Global Outcomes. April 2024.
  38. KDIGO 2021 Clinical Practice Guidelines for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Disease Improving Global Outcomes. March 2021.
  39. Boer IH et al. Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care. October 3, 2022.
igor-kagan-bio

Igor Kagan, MD

Medical Reviewer

Igor Kagan, MD, is an an assistant clinical professor at UCLA. He spends the majority of his time seeing patients in various settings, such as outpatient clinics, inpatient rounds, and dialysis units. He is also the associate program director for the General Nephrology Fellowship and teaches medical students, residents, and fellows. His clinical interests include general nephrology, chronic kidney disease, dialysis (home and in-center), hypertension, and glomerulonephritis, among others. He is also interested in electronic medical record optimization and services as a physician informaticist.

A native of Los Angeles, he graduated cum laude from the University of California in Los Angeles (UCLA) with a bachelor's in business and economics, and was inducted into the Phi Beta Kappa honor society. He then went to the Keck School of Medicine at the University of Southern California (USC) for his medical school education. He stayed at USC for his training and completed his internship and internal medicine residency at the historic Los Angeles County and USC General Hospital. Following his internal medicine residency, Kagan went across town to UCLA's David Geffen School of Medicine for his fellowship in nephrology and training at the UCLA Ronald Reagan Medical Center. After his fellowship he stayed on as faculty at UCLA Health.

Jessica Freeborn

Author

Jessica Freeborn has worked as a health and wellness freelance writer since 2021. She is passionate about encouraging people to take control of their health and stay informed about the latest medical advancements. She has two nursing degrees and has used her healthcare experience to enhance her writing and research.

As someone with type 1 diabetes, she understands the complexities surrounding diabetes management and wants to provide people with accurate information and dispel misconceptions about diabetes treatment.